The quarterly results are the first to include sales of Eli Lilly's new weight loss drug Zepbound, which won FDA approval in early November.
Comments
(・.・;)
There's nothing here…
The quarterly results are the first to include sales of Eli Lilly's new weight loss drug Zepbound, which won FDA approval in early November.